Literature DB >> 8281854

Effect of transforming growth factor-alpha on gastric acid secretion in rats and monkeys.

A Guglietta1, C A Lesch, M Romano, R W McClure, R J Coffey.   

Abstract

The effect of transforming growth factor-alpha was studied in histamine-stimulated gastric acid secretion in monkeys and in pylorus-ligated rats. In monkeys, transforming growth factor-alpha given intravenously in a stepwise manner gradually reduced gastric acid secretion. A dose of 0.1 mmol/kg induced about a 50% inhibition of gastric acid output, while about 100% inhibition of the same parameter, was observed after a dose of 1 nmol/kg. Following a single administration of 1 nmol/kg intravenously in monkey, the maximum inhibitory effect on gastric acid output was reached 60 min after the administration of the drug, when a 91.8% inhibition was observed. Pretreatment values were reached 210-240 min after transforming growth factor-alpha administration. In pylorus-ligated rats, transforming growth factor-alpha, at doses of 9 and 18 nmol/kg produced an almost complete inhibition of gastric acid secretion. In this model, the ED50 was calculated to be 4.5 nmol/kg. Comparison with epidermal growth factor on the same models of gastric acid secretion showed that these two compounds have similar inhibitory potency. However, the effect of transforming growth factor-alpha on gastric acid secretion in monkeys was shorter lasting than that of epidermal growth factor.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8281854     DOI: 10.1007/BF02090079

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  30 in total

1.  Epidermal growth factor and transforming growth factor-alpha: differential intracellular routing and processing of ligand-receptor complexes.

Authors:  R Ebner; R Derynck
Journal:  Cell Regul       Date:  1991-08

2.  Growth factors from murine sarcoma virus-transformed cells.

Authors:  J E de Larco; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1978-08       Impact factor: 11.205

3.  Transforming growth factor-alpha: a more potent angiogenic mediator than epidermal growth factor.

Authors:  A B Schreiber; M E Winkler; R Derynck
Journal:  Science       Date:  1986-06-06       Impact factor: 47.728

4.  Production of transforming growth factor alpha in human pancreatic cancer cells: evidence for a superagonist autocrine cycle.

Authors:  J J Smith; R Derynck; M Korc
Journal:  Proc Natl Acad Sci U S A       Date:  1987-11       Impact factor: 11.205

5.  Inhibition of parietal cell H+ secretion by transforming growth factor alpha: a possible autocrine regulatory mechanism.

Authors:  J J Lewis; J R Goldenring; I M Modlin; R J Coffey
Journal:  Surgery       Date:  1990-08       Impact factor: 3.982

6.  Developmental expression of rat transforming growth factor-alpha mRNA.

Authors:  D C Lee; R Rochford; G J Todaro; L P Villarreal
Journal:  Mol Cell Biol       Date:  1985-12       Impact factor: 4.272

7.  Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.

Authors:  R Derynck; D V Goeddel; A Ullrich; J U Gutterman; R D Williams; T S Bringman; W H Berger
Journal:  Cancer Res       Date:  1987-02-01       Impact factor: 12.701

8.  Distinct vascular actions of epidermal growth factor-urogastrone and transforming growth factor-alpha.

Authors:  B S Gan; M D Hollenberg; K L MacCannell; K Lederis; M E Winkler; R Derynck
Journal:  J Pharmacol Exp Ther       Date:  1987-07       Impact factor: 4.030

9.  Human recombinant transforming growth factor alpha stimulates bone resorption and inhibits formation in vitro.

Authors:  K J Ibbotson; J Harrod; M Gowen; S D'Souza; D D Smith; M E Winkler; R Derynck; G R Mundy
Journal:  Proc Natl Acad Sci U S A       Date:  1986-04       Impact factor: 11.205

10.  An evolutionarily conserved enzyme degrades transforming growth factor-alpha as well as insulin.

Authors:  J V Garcia; B D Gehm; M R Rosner
Journal:  J Cell Biol       Date:  1989-09       Impact factor: 10.539

View more
  9 in total

1.  Cytokine effects on pepsinogen secretion from human peptic cells.

Authors:  M T Serrano; A I Lanas; S Lorente; R Sáinz
Journal:  Gut       Date:  1997-01       Impact factor: 23.059

Review 2.  From wavy hair to naked proteins: the role of transforming growth factor alpha in health and disease.

Authors:  Bhuminder Singh; Robert J Coffey
Journal:  Semin Cell Dev Biol       Date:  2014-03-12       Impact factor: 7.727

3.  Transforming growth factor-alpha (TGF-alpha) levels in human proximal gastrointestinal epithelium. Effect of mucosal injury and acid inhibition.

Authors:  J M Scheiman; K S Meise; J K Greenson; R J Coffey
Journal:  Dig Dis Sci       Date:  1997-02       Impact factor: 3.199

4.  Impact of Helicobacter pylori colonization on immunoreactive epidermal growth factor and transforming growth factor-alpha in gastric juice. Its potential pathogenetic implications.

Authors:  M Marcinkiewicz; B Van Der Linden; D A Peura; G Goldin; S Parolisi; J Sarosiek
Journal:  Dig Dis Sci       Date:  1996-11       Impact factor: 3.199

5.  Transforming growth factor-alpha in vivo stimulates epithelial cell proliferation in digestive tissues of suckling rats.

Authors:  K Hormi; T Lehy
Journal:  Gut       Date:  1996-10       Impact factor: 23.059

6.  Ligands for histamine H(3) receptors modulate cell proliferation and migration in rat oxyntic mucosa.

Authors:  Giuseppina Morini; Daniela Grandi; Walter Schunack
Journal:  Br J Pharmacol       Date:  2002-09       Impact factor: 8.739

Review 7.  Pierre Ménétrier and his disease.

Authors:  Robert J Coffey; Jarred Tanksley
Journal:  Trans Am Clin Climatol Assoc       Date:  2012

8.  Comparison of the antisecretory and antiulcer activity of epidermal growth factor, urogastrone and transforming growth factor alpha and its derivative in rodents in vivo.

Authors:  S M A Bastaki; S I Chandranath; J Singh
Journal:  Mol Cell Biochem       Date:  2002-07       Impact factor: 3.396

9.  Chronic systemic treatment with epidermal growth factor in pigs causes pronounced urothelial growth with accumulation of glycoconjugates.

Authors:  L Vinter-Jensen; C O Juhl; J C Djurhuus; S S Poulsen; E Z Dajani; K D Brown; T F Orntoft; P S Teglbjaerg; E Nexø
Journal:  Am J Pathol       Date:  1995-11       Impact factor: 4.307

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.